| Income Statement | 2025-06-30 | |||
|---|---|---|---|---|
| Research and development expenses | 909,771 | |||
| General and administrative expenses | 2,111,265 | |||
| Total operating expenses | 3,021,036 | |||
| Interest income | 24,915 | |||
| Other expense, net | 262,848 | |||
| Total other expense, net | -237,933 | |||
| Loss before tax expense | -3,258,969 | |||
| Net loss | -3,258,969 | |||
| Foreign currency translation gain, net of taxes | 218,346 | |||
| Total comprehensive loss | -3,040,623 | |||
| Basic (in dollars per share) | -0.16 | |||
| Basic (in shares) | 20,525,699 | |||
| Diluted (in dollars per share) | -0.16 | |||
| Diluted (in shares) | 20,525,699 | |||
Advanced Biomed Inc. (ADVB)
Advanced Biomed Inc. (ADVB)